A new meta-analysis shows meaningful differences among FDA-approved antipsychotic adjuncts for MDD, with lumateperone showing the strongest efficacy and aripiprazole the best overall acceptability.

Among people with major depressive disorder, treatment with semaglutide reduces the perceived cost of effort and improves motivation.

What social risk factors affecting your patients may affect their risk of major depressive disorder more than they realize?

(Hinterhaus Productions/Getty Images Plus) Cannabis use disorder has been strongly linked with major depressive disorder in a ...

Ketamine has been hailed as a fast-acting, effective treatment for major depression. But new research questions whether the ...

While they share similar depressive and cognitive symptoms, the biological underpinnings of bipolar disorder and major ...

Phase 2b Trial Met Primary Endpoint, Demonstrating Strong Efficacy and Favorable Safety Profile; Phase 3 PlannedCHENGDU, China and ROCKAWAY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Kanghong ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

Neurons and white blood cells differ greatly in shape, function, and location within the body. However, researchers at the ...

Study identifies a specific link between insulin resistance, brain structure, and cognitive impairment in Bipolar Disorder, ...